Bank Pictet & Cie (Europe)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-6,138
| Closed | -$343K | – | 264 |
|
2023
Q4 | $343K | Sell |
6,138
-233
| -4% | -$13K | 0.01% | 219 |
|
2023
Q3 | $263K | Sell |
6,371
-92
| -1% | -$3.8K | 0.01% | 228 |
|
2023
Q2 | $361K | Sell |
6,463
-252
| -4% | -$14.1K | 0.01% | 207 |
|
2023
Q1 | $375K | Hold |
6,715
| – | – | 0.02% | 141 |
|
2022
Q4 | $245K | Buy |
+6,715
| New | +$245K | 0.01% | 153 |
|
2022
Q2 | – | Sell |
-4,234
| Closed | -$322K | – | 179 |
|
2022
Q1 | $322K | Buy |
4,234
+428
| +11% | +$32.6K | 0.01% | 144 |
|
2021
Q4 | $567K | Buy |
3,806
+467
| +14% | +$69.6K | 0.02% | 127 |
|
2021
Q3 | $486K | Sell |
3,339
-309
| -8% | -$45K | 0.02% | 133 |
|
2021
Q2 | $714K | Buy |
3,648
+1,556
| +74% | +$305K | 0.02% | 115 |
|
2021
Q1 | $379K | Buy |
+2,092
| New | +$379K | 0.02% | 134 |
|